These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32474521)

  • 1. Correlation between the changes of serum COX 2, APE1, VEGF, TGF-β and TSGF levels and prognosis in patients with osteosarcoma before and after treatment.
    Zhang Q; Dong G; Wang F; Ding W
    J Cancer Res Ther; 2020; 16(2):335-342. PubMed ID: 32474521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The correlation between the level of serum VEGF and bFGF with metastasis and prognosis of osteosarcoma].
    Chen GL; Lin HB; Wu XW; Li RY; Chen XH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Dec; 27(12):1343-5. PubMed ID: 22368795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study.
    Tabone MD; Brugières L; Piperno-Neumann S; Selva MA; Marec-Bérard P; Pacquement H; Lervat C; Corradini N; Gentet JC; Couderc R; Chevance A; Mahier-Ait Oukhatar C; Entz-Werle N; Blay JY; Le Deley MC
    BMC Cancer; 2017 Jun; 17(1):419. PubMed ID: 28619014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical predictive value of serum angiogenic factor in patients with osteosarcoma.
    Chen Z; Chen QX; Hou ZY; Hu J; Cao YG
    Asian Pac J Cancer Prev; 2012; 13(9):4823-6. PubMed ID: 23167426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of apparent diffusion coefficient combined with serum tumor markers detection in evaluating neoadjuvant chemotherapy for osteosarcoma].
    Wang Z; Liu L; Song YX; Zhang H; She W; Qian YW
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(13):1012-1016. PubMed ID: 32294859
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclooxygenase-2 overexpression predicts poor survival in patients with high-grade extremity osteosarcoma: a pilot study.
    Urakawa H; Nishida Y; Naruse T; Nakashima H; Ishiguro N
    Clin Orthop Relat Res; 2009 Nov; 467(11):2932-8. PubMed ID: 19326179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of interferon alpha and ribavirin treatment on serum levels of transforming growth factor-beta1, vascular endothelial growth factor, and basic fibroblast growth factor in patients with chronic hepatitis C.
    Janczewska-Kazek E; Marek B; Kajdaniuk D; Borgiel-Marek H
    World J Gastroenterol; 2006 Feb; 12(6):961-5. PubMed ID: 16521228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The level of vascular endothelial growth factor as a predictor of a poor prognosis in osteosarcoma.
    Kaya M; Wada T; Nagoya S; Sasaki M; Matsumura T; Yamashita T
    J Bone Joint Surg Br; 2009 Jun; 91(6):784-8. PubMed ID: 19483233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of hypoxia-inducible factor 1α in osteosarcoma and its value in predicting chemosensitivity].
    Chen Y; Wang CM; Shi YQ; Yang Y
    Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):899-904. PubMed ID: 23336375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of vascular endothelial growth factor as a tumour marker in osteosarcoma: a prospective study.
    Rastogi S; Kumar R; Sankineani SR; Marimuthu K; Rijal L; Prakash S; Jalan D; Khan SA; Sharma MC
    Int Orthop; 2012 Nov; 36(11):2315-21. PubMed ID: 23015149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three hematological indexes that may serve as prognostic indicators in patients with primary, high-grade, appendicular osteosarcoma.
    Hu K; Wang Z; Lin P; Wen Z; Ren H; Sun L; Li H; Li B; Wang S; Zhou X; Tengwang S; Xu L; Ye Z
    Oncotarget; 2017 Jun; 8(26):43130-43139. PubMed ID: 28562345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China.
    Han J; Yong B; Luo C; Tan P; Peng T; Shen J
    World J Surg Oncol; 2012 Feb; 10():37. PubMed ID: 22333159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between serum biomarker levels and clinical presentation of human osteosarcomas.
    Limmahakhun S; Pothacharoen P; Theera-Umpon N; Arpornchayanon O; Leerapun T; Luevitoonvechkij S; Pruksakorn D
    Asian Pac J Cancer Prev; 2011; 12(7):1717-22. PubMed ID: 22126551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apurinic/apyrimidinic endonuclease 1 induced upregulation of fibroblast growth factor 2 and its receptor 3 induces angiogenesis in human osteosarcoma cells.
    Ren T; Qing Y; Dai N; Li M; Qian C; Yang Y; Cheng Y; Li Z; Zhang S; Zhong Z; Wang D
    Cancer Sci; 2014 Feb; 105(2):186-94. PubMed ID: 24329908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in patients with soft-tissue sarcoma.
    Graeven U; Andre N; Achilles E; Zornig C; Schmiegel W
    J Cancer Res Clin Oncol; 1999 Oct; 125(10):577-81. PubMed ID: 10473871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
    Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C
    Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apurinic/apyrimidinic endonuclease 1 regulates angiogenesis in a transforming growth factor β-dependent manner in human osteosarcoma.
    Jiang X; Shan J; Dai N; Zhong Z; Qing Y; Yang Y; Zhang S; Li C; Sui J; Ren T; Li M; Wang D
    Cancer Sci; 2015 Oct; 106(10):1394-401. PubMed ID: 26250694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating angiogenic cytokines in multiple myeloma and related disorders.
    Urba ska-Rys H; Wierzbowska A; Robak T
    Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum TSGF and miR-214 levels in patients with hepatocellular carcinoma and their predictive value for the curative effect of transcatheter arterial chemoembolization.
    Tang L; Zhang XM
    Ann Palliat Med; 2020 Jul; 9(4):2111-2117. PubMed ID: 32762227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma.
    Akbulut H; Altuntas F; Akbulut KG; Ozturk G; Cindoruk M; Unal E; Icli F
    Cytokine; 2002 Nov; 20(4):184-90. PubMed ID: 12543084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.